| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Advances and challenges in stroke rehabilitation
|
Stinear, Cathy M
|
|
|
19 |
4 |
p. 348-360
|
article
|
| 2 |
Advances in oral immunomodulating therapies in relapsing multiple sclerosis
|
Derfuss, Tobias
|
|
|
19 |
4 |
p. 336-347
|
article
|
| 3 |
A radical proposal for the EU budget: brain health
|
The Lancet Neurology,
|
|
|
19 |
4 |
p. 279
|
article
|
| 4 |
Cannabidiol with clobazam for seizures associated with Dravet and Lennox-Gastaut syndromes
|
Lamb, Alan
|
|
|
19 |
4 |
p. 290-291
|
article
|
| 5 |
Correction to Lancet Neurol 2020; 19: 234–46
|
|
|
|
19 |
4 |
p. e4
|
article
|
| 6 |
Correction to Lancet Neurol 2020; 19: 247–54
|
|
|
|
19 |
4 |
p. e4
|
article
|
| 7 |
Dispelling myths and legends about dementia
|
Ranscombe, Peter
|
|
|
19 |
4 |
p. 297
|
article
|
| 8 |
Interpretation of risk loci from genome-wide association studies of Alzheimer's disease
|
Andrews, Shea J
|
|
|
19 |
4 |
p. 326-335
|
article
|
| 9 |
New paradigms of clinical trial design for genetic prion diseases
|
Aguzzi, Adriano
|
|
|
19 |
4 |
p. 284-285
|
article
|
| 10 |
Nusinersen in adults with 5q spinal muscular atrophy: a non-interventional, multicentre, observational cohort study
|
Hagenacker, Tim
|
|
|
19 |
4 |
p. 317-325
|
article
|
| 11 |
Nusinersen in adults with spinal muscular atrophy: new challenges
|
Mercuri, Eugenio
|
|
|
19 |
4 |
p. 283-284
|
article
|
| 12 |
Old and new breakthroughs in neuromyelitis optica
|
Hartung, Hans-Peter
|
|
|
19 |
4 |
p. 280-281
|
article
|
| 13 |
Parkinson's disease in the MENASA countries
|
Khalil, Hanan
|
|
|
19 |
4 |
p. 293-294
|
article
|
| 14 |
Rethinking multiple sclerosis treatment strategies
|
Filippi, Massimo
|
|
|
19 |
4 |
p. 281-282
|
article
|
| 15 |
Safety and efficacy of rituximab in neuromyelitis optica spectrum disorders (RIN-1 study): a multicentre, randomised, double-blind, placebo-controlled trial
|
Tahara, Masayuki
|
|
|
19 |
4 |
p. 298-306
|
article
|
| 16 |
Safety of adjunctive treatment with cenobamate in patients with uncontrolled focal seizures
|
Mudigoudar, Basanagoud
|
|
|
19 |
4 |
p. 288
|
article
|
| 17 |
Safety of adjunctive treatment with cenobamate in patients with uncontrolled focal seizures – Authors' reply
|
Krauss, Gregory L
|
|
|
19 |
4 |
p. 288-289
|
article
|
| 18 |
Shane Liddelow
|
|
|
|
19 |
4 |
p. 296
|
article
|
| 19 |
T cells in Alzheimer's disease: space invaders
|
McManus, Róisín M
|
|
|
19 |
4 |
p. 285-287
|
article
|
| 20 |
Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study
|
He, Anna
|
|
|
19 |
4 |
p. 307-316
|
article
|
| 21 |
Towards a treatment for genetic prion disease: trials and biomarkers
|
Vallabh, Sonia M
|
|
|
19 |
4 |
p. 361-368
|
article
|
| 22 |
Troels Staehelin Jensen—dissecting pain
|
Kirby, Tony
|
|
|
19 |
4 |
p. 292
|
article
|
| 23 |
Valuing qualitative alongside quantitative research
|
Ranscombe, Peter
|
|
|
19 |
4 |
p. 295-296
|
article
|
Journal description